Commenting on the inoculations, the European Union’s (EU) Internal Market Commissioner Thierry Breton said that there will be enough vaccines for 70% of the bloc's population by July.
This comes after Pfizer and BioNTech said in a statement on Monday, the bloc will receive additional 100 million doses from the pharma giants.
Meanwhile, the European Medicines Agency (EMA) is set to publish its verdict on Johnson & Johnson's single-dose vaccine later on Tuesday.
EUR/USD is off the highs but trades with moderate gains above 1.2050 amid the US dollar’s weakness and the EU’s vaccine optimism. However, rising Treasury yields and the risk-off action in the European equities appear to be capping the gains in the spot.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.